Astrana Health, Inc. reported $3.84B of revenue over the trailing twelve months, +59% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $3.84B (to Q2 2026). Net income: $41M, trailing twelve months to Q2 2026. Free cash flow: $94M, trailing twelve months to Q2 2026. Operating margin: 2.6%, trailing twelve months to Q2 2026.

ASTHAstrana Health, Inc.

Healthcare

$37.58+35% 1Y

$37.58

$18.1652 weeks$49.01

ASTH as reported

Astrana Health, Inc. reported $3.84B of revenue over the trailing twelve months, +59% on the year before. 11 reported series are charted on this page, each one as filed.

$3.84B

Revenue, trailing twelve months · to Q2 2026 · +59% against the twelve months before

Net income: $41M
Net income · +61% year on year · trailing twelve months to Q2 2026
Free cash flow: $94M
Free cash flow · −22% year on year · trailing twelve months to Q2 2026
Operating margin: 2.6%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ASTH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$3.84B	+59%	Q2 2026
Net income	$41M	+61%	Q2 2026
EPS	$0.83	+60%	Q2 2026
Gross margin	10%	n/a	Q2 2026
Operating margin	2.6%	n/a	Q2 2026
Net margin	1.0%	n/a	Q2 2026
ROE	3.2%	n/a	Q2 2026
ROA	1.1%	n/a	Q2 2026
ROIC	4.7%	n/a	Q2 2026
Free cash flow	$94M	−22%	Q2 2026
P/E	45.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.